Category — Medical Technology

U.S. to India: Revise Stance on Capping Med Device Prices

The Government of India has limited retail prices of medical devices such as knee implants and heart stents by up to 75 percent to make them more affordable, but the $5 billion Indian medical-technology industry that includes Abbott Laboratories, Boston Scientific Corp, and Johnson & Johnson, among others, has protested these moves, saying they hurt innovation, and future investment.

SYNERGY StentReuters reports that a senior United States Trade Representative official said they were pressing India to not extend price caps to other devices, allow for higher pricing for technologically advanced equipment, and let companies withdraw their products if they wish to.

With margins of profit exceeding 400 percent for some devices, the government has equated such high margins to ‘illegal profiteering’, and Prime Minister Modi says that providing affordable healthcare to patients takes precedence over the interests of companies.

Tanoubi Ngangom, an associate fellow for healthcare at the Observer Research Foundation based in New Delhi, says India should develop policies based on its requirements and not succumb to diplomatic pressure.

October 8, 2017   No Comments

Indian Council of Medical Research Partners on Vaccine R&D

The Indian Council of Medical Research (ICMR) entered into an agreement with the International Vaccine Institute (IVI) to collaborate on vaccine research and development. India will commit $500,000 annually for a stake in IVI. According to the Memorandum of Understanding, ICMR will focus on research and development of vaccines to combat various infectious diseases such as tuberculosis, malaria, chikungunya and influenza, among others.

Image of Vaccines
 ICMR director general Soumya Swaminathan outlined the partnership:
  • Vaccine candidates developed in IVI labs can be transferred to one of the companies in India for further development
  • IVI will facilitate further global testing of vaccine candidates developed in India’s labs by linking developers here with global partners
  • The partnership will help with capacity building for clinical trials within India
  • IVI will support in conducting phase II and III trials for the candidate, if required

Jerome H. Kim, director general of IVI said that India supplies 60% of the world’s vaccines for vaccine-preventable diseases and contributes up to 80% of the United Nations’ annual vaccine purchases, reports the Economic Times. “We look forward to having India’s representation on the IVI Board of Trustees, which will increase engagement with Indian academia and industry even further,” Kim said.

September 1, 2017   No Comments

India a Top 10 Trade Partner for USA

India is currently U.S.’s 9th largest goods trading partner with $67.7 billion in total (two way) goods trade during 2016. Goods exports totaled $21.7 billion; goods imports totaled $46.0 billion. The U.S. goods trade deficit with India was $24.3 billion in 2016.

According to the U.S. Census Bureau, the country’s top imports include jewelry, silverware, sporting and athletic goods, toys, basic chemicals, pharmaceuticals, medicines, apparel, accessories, textiles, and coal and petroleum products.

U.S. top exports include precious stones, pearls, metals, basic chemicals, medical and surgical equipment, metal manufacturing, computers, electronic products, and machinery other than electrical.

The tables below compare the figures for the first five months of U.S. – India trade for 2016 and 2017. The table also lists the trade figures for the first five months of 2009 which show that the trade deficit in that year was less that in recent years.  All figures below are in millions of U.S. dollars on a nominal basis and not seasonally adjusted.

Month, Year Exports Imports Month, Year Exports Imports
Jan ’17    1,703.0     3,791.9 Jan ’09


1,139.8 1,833.5
Jan ’16    1,485.7     3,693.3
Feb ’17    1,937.8      3,474.3 Feb ’09    1,046.8  1,579.0
Feb ’16    1,526.3      3,660.9
Mar ’17     2,114.5        4,143.9 Mar ’09    1,123.5  1,773.0
Mar ’16     1,834.5        3,997.0
Apr ’17     1,939.4        3,730.5 Apr ’09     1,268.8          1,799.2
Apr ’16     1,772.7        3,678.3
May ’17      2,056.9        4,531.1 May ’09     1,507.5  1,580.8
May ’16      1,585.9        4,124.9

Comparison of U.S. trade in goods with India for Jan to May in 2017 and 2016, and 2009.


August 4, 2017   No Comments

India’s Largest Medical Device Park Opens for Business

At 250 acres, India’s largest medical devices park started operations in the outskirts of Hyderabad in the state of Telangana. K.T. Rama Rao, Minister for IT, Municipal Administration and Urban Development and Industries, who inaugurated the park, said, “We will provide all the necessary facilities to develop this park into a dedicated ecosystem for MedTech innovation and manufacturing of medical devices.”

With an aim to promote innovation through incubation, the facility will work closely with the Indian Institute of Information Technology Hyderabad, which will provide expertise in medical technology utilization for alloy works, plastics and medical electronics. It will also provide guidance in the use of biotech components such as DNA proteins and reagents, IoT, imaging, voice and data processing, among others, reports Pharmabiz.

Medical Devices Park Telangana

Fourteen companies, including Apollo Hospitals, Cyient Limited, Sandor Medicaids, Healthware Private Ltd, Sanofi Shantha Biotech, and Hetero Drugs have been allocated 50 acres of land in the park, where they will invest over $65 million (Rs 425.59 crore) and create direct employment for nearly 4,000 people.

July 20, 2017   No Comments

India’s Health Ministry to Regulate Prices of Critical Medical Devices

Critical medical devices and diagnostic equipment will be  regulated by India’s health ministry. Under the Medical Devices Rules, 2017, which will come into effect from January 1, 2018, prices of devices such as catheters, stents and orthopedic implants, heart valves, intra-ocular lenses, syringes and needles will be regulated by the government.

“The devices intended for internal or external use in diagnosis, treatment, mitigation or prevention of disease or disorder in human beings or animals, as may be specified from time to time by the central [federal] government by notification in official gazette, after consultation with the Board, fall under the definition of drugs,” Drugs Controller General of India G.N. Singh said in a notice, giving out a list of 15 medical devices notified so far .

The new rules will also require critical devices to undergo trials in India before they are approved for launch. Implantable devices such as stents will be part of the high risk category and will be monitored directly by the government regulator, reports the Times of India.

Medical Equipment

July 20, 2017   No Comments